Massive Insights Information

Massive Insights helps life sciences commercial teams answer the questions that decide a launch: where the opportunity really is, who matters most, and where to focus first. We work with emerging biotechs approaching their first launch and with established brands that need a sharper read on their market. Our approach starts with the question, not the dataset. We fuse hundreds of public and licensed sources (claims, prescriptions, trials, referrals, industry payments, affiliations and more) to find the weak signals no single dataset shows. Then senior life sciences consultants turn those signals into a call you can act on. The machinery finds the signals. Experienced people make the call. Across the launch lifecycle: Early pre-commercial. Build an independent, evidence-based model of the market before major commitments lock in. Close to launch. Turn the model into bets: which physicians, accounts and geographies deserve your finite resources, and why. Early post-launch. See quickly where reality is diverging from the plan, why, and what to change. Every answer comes with its evidence chain: sources, assumptions and confidence. AI generates interpretations. Our evidence architecture constrains them to the ones you can defend. Since 2012, Massive Insights has delivered 1,500+ projects for data-rich companies across life sciences, financial services, utilities and CPG. Beyond life sciences, we help organizations modernize data platforms, build analytics that get used, and put applied AI to work on problems they had shelved. We also host the AI Executive Dinner Series in Toronto and Chicago. Based in Toronto. Working across North America.